Description:

Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01130753

Link:

https://clinicaltrials.gov/show/NCT01130753

Keywords:
Versions (1) ▾
  1. 5/27/18
Copyright Holder:
See clinicaltrials.gov
Uploaded on:

May 27, 2018

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lung Neoplasms NCT01130753

Eligibility Lung Neoplasms NCT01130753

Inclusion Criteria
Exclusion Criteria